
    
      This study will assess the programmatic implications (including feasibility, acceptability,
      risks and benefits) at the community level of the introduction of misoprostol and/or oxytocin
      in UnijectTM for the prevention of PPH and will help to identify the appropriate niche for
      both drugs.
    
  